OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effectiveness of golimumab in patients with ulcerative colitis: results of a real-life study in Switzerland
Kathrin Perrig, Niklas Krupka, Sebastian Bruno Ulrich Jordi, et al.
Therapeutic Advances in Gastroenterology (2022) Vol. 15
Open Access | Times Cited: 7
Kathrin Perrig, Niklas Krupka, Sebastian Bruno Ulrich Jordi, et al.
Therapeutic Advances in Gastroenterology (2022) Vol. 15
Open Access | Times Cited: 7
Showing 7 citing articles:
AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis
Siddharth Singh, Edward V. Loftus, Berkeley N. Limketkai, et al.
Gastroenterology (2024) Vol. 167, Iss. 7, pp. 1307-1343
Closed Access | Times Cited: 13
Siddharth Singh, Edward V. Loftus, Berkeley N. Limketkai, et al.
Gastroenterology (2024) Vol. 167, Iss. 7, pp. 1307-1343
Closed Access | Times Cited: 13
Structure and regulatory mechanisms of food‐derived peptides in inflammatory bowel disease: A review
Wenpei Qiu, Zhicheng Wang, Qirui Liu, et al.
Food Science & Nutrition (2024) Vol. 12, Iss. 9, pp. 6055-6069
Open Access | Times Cited: 3
Wenpei Qiu, Zhicheng Wang, Qirui Liu, et al.
Food Science & Nutrition (2024) Vol. 12, Iss. 9, pp. 6055-6069
Open Access | Times Cited: 3
Effectiveness and Safety Profiles of Biological Therapies in Inflammatory Bowel Disease: Real Life Data from an Active Pharmacovigilance Project
María Antonietta Barbieri, Anna Viola, Giuseppe Cicala, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3280-3280
Open Access | Times Cited: 10
María Antonietta Barbieri, Anna Viola, Giuseppe Cicala, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3280-3280
Open Access | Times Cited: 10
Effectiveness and Factors Associated with Response to Golimumab in Japanese Patients with Ulcerative Colitis in Real Clinical Practice: The Phoenix Study
Daisuke Hirayama, Satoshi Motoya, Toshifumi Ashida, et al.
Inflammatory Intestinal Diseases (2023) Vol. 8, Iss. 3, pp. 115-127
Open Access | Times Cited: 6
Daisuke Hirayama, Satoshi Motoya, Toshifumi Ashida, et al.
Inflammatory Intestinal Diseases (2023) Vol. 8, Iss. 3, pp. 115-127
Open Access | Times Cited: 6
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry
Margalida Calafat, Paola Torres, Joan Toscá, et al.
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access
Margalida Calafat, Paola Torres, Joan Toscá, et al.
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access
Patient-reported continuous clinical response to golimumab in adults with moderately to severely active ulcerative colitis: results from GO OBSERVE, a real-world European observational study
Marc Ferrante, Anja Schirbel, Marieke Pierik, et al.
European Journal of Gastroenterology & Hepatology (2022) Vol. 34, Iss. 6, pp. 646-654
Closed Access | Times Cited: 1
Marc Ferrante, Anja Schirbel, Marieke Pierik, et al.
European Journal of Gastroenterology & Hepatology (2022) Vol. 34, Iss. 6, pp. 646-654
Closed Access | Times Cited: 1
